The Latest Headlines at American Banking and Market News
Needham & Company LLC Reiterates “Hold” Rating for First Advantage (NYSE:FA)
First Advantage (NYSE:FA – Get Free Report)‘s stock had its “hold” rating reaffirmed by equities research analysts at Needham & Company LLC in a report released on Monday, Benzinga reports. FA has been... More of this article »
HC Wainwright Cuts EyePoint Pharmaceuticals (NASDAQ:EYPT) Price Target to $30.00
EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) had its price objective dropped by equities researchers at HC Wainwright from $33.00 to $30.00 in a report released on Monday, Benzinga reports. The firm currently has... More of this article »
Clearside Biomedical (NASDAQ:CLSD) Price Target Lowered to $5.00 at HC Wainwright
Clearside Biomedical (NASDAQ:CLSD – Get Free Report) had its price objective decreased by equities researchers at HC Wainwright from $6.00 to $5.00 in a note issued to investors on Monday, Benzinga reports. The firm presently... More of this article »
Ocuphire Pharma (NASDAQ:OCUP) Rating Reiterated by HC Wainwright
Ocuphire Pharma (NASDAQ:OCUP – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a note issued to investors on Monday, Benzinga reports. They presently have a $20.00 price target on... More of this article »
HC Wainwright Reaffirms Buy Rating for 4D Molecular Therapeutics (NASDAQ:FDMT)
4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research report issued on Monday, Benzinga reports. They presently... More of this article »
Merus (NASDAQ:MRUS) Rating Reiterated by Needham & Company LLC
Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Needham & Company LLC in a research note issued on Monday, Benzinga reports. They currently have a $66.00... More of this article »
Savara (NASDAQ:SVRA) Receives “Buy” Rating from HC Wainwright
Savara (NASDAQ:SVRA – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research note issued to investors on Monday, Benzinga reports. They currently have a... More of this article »
Bank of America Initiates Coverage on Centuri (NYSE:CTRI)
Analysts at Bank of America started coverage on shares of Centuri (NYSE:CTRI – Get Free Report) in a research report issued on Monday, Marketbeat reports. The brokerage set a “neutral” rating and a $26.00 price target... More of this article »
Omega Therapeutics (NASDAQ:OMGA) Stock Rating Reaffirmed by HC Wainwright
Omega Therapeutics (NASDAQ:OMGA – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports.... More of this article »
Cogent Biosciences (NASDAQ:COGT) Earns Buy Rating from HC Wainwright
Cogent Biosciences (NASDAQ:COGT – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research note issued to investors on Monday, Benzinga reports. They presently have a... More of this article »
Union Bankshares (NASDAQ:UNB) Coverage Initiated at StockNews.com
Research analysts at StockNews.com initiated coverage on shares of Union Bankshares (NASDAQ:UNB – Get Free Report) in a research report issued on Wednesday. The brokerage set a “hold” rating on the bank’s stock. Union... More of this article »
StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV)
Research analysts at StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report released on Wednesday. The firm set a “hold” rating on the biopharmaceutical company’s... More of this article »
FTC Solar (NASDAQ:FTCI) Receives Buy Rating from HC Wainwright
FTC Solar (NASDAQ:FTCI – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. They presently have a $1.50... More of this article »